<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A4090D5-D795-4C4B-8A6B-00D25830130F"><gtr:id>4A4090D5-D795-4C4B-8A6B-00D25830130F</gtr:id><gtr:name>University of Duisburg-Essen</gtr:name><gtr:address><gtr:line1>University of Duisburg-Essen</gtr:line1><gtr:line2>Geibelstrase 41</gtr:line2><gtr:line4>Duisburg</gtr:line4><gtr:line5>D-47057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A4090D5-D795-4C4B-8A6B-00D25830130F"><gtr:id>4A4090D5-D795-4C4B-8A6B-00D25830130F</gtr:id><gtr:name>University of Duisburg-Essen</gtr:name><gtr:address><gtr:line1>University of Duisburg-Essen</gtr:line1><gtr:line2>Geibelstrase 41</gtr:line2><gtr:line4>Duisburg</gtr:line4><gtr:line5>D-47057</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BEF4AFAA-CE97-458A-8077-93F9C5B01325"><gtr:id>BEF4AFAA-CE97-458A-8077-93F9C5B01325</gtr:id><gtr:firstName>George</gtr:firstName><gtr:surname>Kassiotis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117581330"><gtr:id>70EC902D-A7B8-4891-8016-37200CC405DB</gtr:id><gtr:title>Antiviral immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117581330</gtr:grantReference><gtr:abstractText>Viral infections represent a major challenge to the immune system. Many viruses cause acute infections in humans, which can be rapidly fatal within days (e.g. influenza A and smallpox viruses). In contrast, many other viruses are able to persist chronically in infected individuals, despite the induction of an immune response (e.g. HIV, HTLV and hepatitis and herpes viruses) and generally the vast majority of individuals are chronically infected by at least one virus. These viruses can also be fatal, but typically after a prolonged incubation period, which can last up to several decades. Our aim is to better understand basic aspects of viral disease pathogenesis, the viral and host characteristics that determine viral persistence and clinical outcome and the quality of the immune response that can afford immune protection against viral infection. The main emphasis is placed on chronic viral infections and, in particular, retroviral infections. Current studies in appropriate mouse models address the mechanisms, by which the composition and timing of cell-mediated and antibody-mediated host immune response is regulated, the mechanisms responsible for what we call immunological memory, and lastly their practical consequences for the design of preventive and therapeutic vaccination strategies, able to induce long-term protective immunity against retroviral infection. In addition, current research concentrates on the protective or pathological immune response to influenza A infection.</gtr:abstractText><gtr:technicalSummary>Vaccines against many chronic viral infections are still lacking. In these cases, natural infection does not elicit an immune response strong enough to clear the infection and, therefore, vaccination should aim to induce a quantitatively and/or qualitatively better response. This has not been achieved to date and further research into the basic aspects of immune-mediated protection and immunological memory is needed. Furthermore, protection against most persistent viruses relies primarily, or in addition to neutralising antibodies, on cell-mediated immunity. Thus, a better understanding of the protective value and the induction and maintenance of a protective T cell response in chronic viral infection will be essential for the development of effective vaccines. The aim of our research programme is two-fold: firstly, to gain a better understanding of the basic aspects of viral disease pathogenesis, the viral and host characteristics that determine viral persistence and clinical outcome and the correlates of a protective immune response, and secondly, to use this knowledge in the design of preventive and therapeutic vaccination strategies, able to induce or enhance long-term protective immunity against viral infection. Central to our approach is the use of appropriate animal models for infection with the relevant viral pathogens. Our experimental system of choice is the mouse as its haematopoietic system has been extensively studied and in addition to the accumulated knowledge there exists a vast array of reagents and genetic manipulation methodologies that facilitate the studies to a level unknown for many other organisms. Furthermore, its physiology and response to infection bear extensive similarities to the human, thus making the findings more relevant in terms of usefulness. To maintain the delicate evolutionary balance between viruses and their hosts in our studies, we have employed the murine leukaemia virus (MLV), a natural mouse virus, as the model pathogen. Murine leukaemia viruses are retroviruses which cause chronic infection in susceptible strains on mice, and may induce diverse outcomes, such as leukaemia, immune suppression and immunodeficiency, depending on the mouse and virus strain employed. In addition, our current research also involves the study of acute, cytopathic viral infections, such as influenza A infection, for which human influenza A viruses are used. These experimental systems are instrumental both in dissecting the basic mechanisms of viral disease and immune protection, as well as in investigating the efficacy of novel vaccination strategies in a pre-clinical setting.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4415364</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Duisburg-Essen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>FV-specific TCR transgenic progect</gtr:description><gtr:id>99B18CA6-D751-4F7A-AADE-439CF7823785</gtr:id><gtr:impact>19828756</gtr:impact><gtr:outcomeId>4F2AE1AF7EE-1</gtr:outcomeId><gtr:partnerContribution>Article 19828756</gtr:partnerContribution><gtr:piContribution>Article 19828756</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Malaria-influenza project</gtr:description><gtr:id>7169E233-2CC0-4603-A497-B37E38ADE3FE</gtr:id><gtr:impact>Joint PhD supervision/project</gtr:impact><gtr:outcomeId>8001D951F2E-1</gtr:outcomeId><gtr:partnerContribution>Joint PhD supervision/project</gtr:partnerContribution><gtr:piContribution>Joint PhD supervision/project</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Endogenous retrovirus</gtr:description><gtr:id>A3302440-6D97-41D0-86E2-7D89C0C2148E</gtr:id><gtr:impact>23103862
22439680
23864388</gtr:impact><gtr:outcomeId>RhArMapzivr-1</gtr:outcomeId><gtr:partnerContribution>exertise in endogenous retroviruses in mice</gtr:partnerContribution><gtr:piContribution>study of endogenous retroviruses in mice</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>274736</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK cancer immunology project grant</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C55533/A22158</gtr:fundingRef><gtr:id>6B1E25E6-531F-41F7-97F9-9C49541E4807</gtr:id><gtr:outcomeId>58c6a271297908.13591121</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>996000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome trust - new investigator award</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>102898/Z/13/Z</gtr:fundingRef><gtr:id>A672A03E-50CE-44BB-BE8D-42AA084ABEE9</gtr:id><gtr:outcomeId>54577c36340685.14245587</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Genetically modified mice with increased susceptibility to murine retroviruses or increased frequency of retrovirus-specific T cells</gtr:description><gtr:id>BA814D77-3D49-4595-B6AD-3A2D6AC975E5</gtr:id><gtr:impact>Revision of basic knowledge regarding the pathogenesis and immune control of retroviral infection</gtr:impact><gtr:outcomeId>1D25414AFE8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genetically modified mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6FF55E1A-977E-4F51-ACC8-E22E9DFC70EE</gtr:id><gtr:title>Endogenous retroviruses and the development of cancer.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a54e4ccd802f58d67f9eef3a0a2961"><gtr:id>e5a54e4ccd802f58d67f9eef3a0a2961</gtr:id><gtr:otherNames>Kassiotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4eba028787.50971363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22DE5EFB-315F-43E3-ABFB-C46BC3FB7384</gtr:id><gtr:title>CD4+ memory T cells: functional differentiation and homeostasis.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b347ab0b39d9f39c00913abba35e548"><gtr:id>6b347ab0b39d9f39c00913abba35e548</gtr:id><gtr:otherNames>Stockinger B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>56cc4ebea55177.08300826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>131B136D-F8AD-429E-A1A4-8D90DE498B09</gtr:id><gtr:title>Generalized immune activation as a direct result of activated CD4+ T cell killing.</gtr:title><gtr:parentPublicationTitle>Journal of biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266709da30c6d35403936371e559db48"><gtr:id>266709da30c6d35403936371e559db48</gtr:id><gtr:otherNames>Marques R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-4924</gtr:issn><gtr:outcomeId>56cc4ebda74729.92304486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>697370C9-3465-4589-BB8F-AFE4C33E6A7E</gtr:id><gtr:title>IL-2-independent and TNF-a-dependent expansion of V?5+ natural regulatory T cells during retrovirus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8900d937188a4b1ae357fe80210a705a"><gtr:id>8900d937188a4b1ae357fe80210a705a</gtr:id><gtr:otherNames>Myers L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4ebb267619.36764035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40EB62ED-0369-4DD3-A28C-929280A7A396</gtr:id><gtr:title>Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d9d8852e01c123613ea93ead3bf6802"><gtr:id>5d9d8852e01c123613ea93ead3bf6802</gtr:id><gtr:otherNames>Antunes I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56cc4ebcb3aa70.42771824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>963F9D2B-7AE0-4AA8-B832-501CED78F884</gtr:id><gtr:title>Recovery of an antiviral antibody response following attrition caused by unrelated infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a7abbc8e356782333c54866dec68375"><gtr:id>7a7abbc8e356782333c54866dec68375</gtr:id><gtr:otherNames>Ng DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cc4eba778464.41601098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA64E2E-E357-4B6B-AF13-7C83D67C6B2E</gtr:id><gtr:title>Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51f53a5722b41806d66a0ed751ba092"><gtr:id>d51f53a5722b41806d66a0ed751ba092</gtr:id><gtr:otherNames>Thorborn G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4eb7da2043.25794962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46402BE6-2EF3-4E48-9F71-3822B4DCFE4A</gtr:id><gtr:title>Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21235522676f3848d94d0de56d316aeb"><gtr:id>21235522676f3848d94d0de56d316aeb</gtr:id><gtr:otherNames>Merkenschlager J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56cc4eb76b5844.83853024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FD8241E-AB6B-46A6-BCE7-B224F95D1C12</gtr:id><gtr:title>Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/637a0666c3dde6fc24317164d6b442c9"><gtr:id>637a0666c3dde6fc24317164d6b442c9</gtr:id><gtr:otherNames>Nair S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>56cc4ebc463244.60214566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42BD6692-552E-4C8A-AB09-BBB88413C21E</gtr:id><gtr:title>Mechanisms of control of acute Friend virus infection by CD4+ T helper cells and their functional impairment by regulatory T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa7191ef2da58c9816174fb7a7a9760a"><gtr:id>fa7191ef2da58c9816174fb7a7a9760a</gtr:id><gtr:otherNames>Nair SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56cc4ebced6a04.88221633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0181347F-7D13-4E75-A786-62902FEEE101</gtr:id><gtr:title>Microarray analysis reveals global modulation of endogenous retroelement transcription by microbes.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>56cc4eb81af0d6.17937528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071CFFB9-40FC-4D8B-A183-A56BBAFE65A5</gtr:id><gtr:title>Effective T helper cell responses against retroviruses: are all clonotypes equal?</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51f53a5722b41806d66a0ed751ba092"><gtr:id>d51f53a5722b41806d66a0ed751ba092</gtr:id><gtr:otherNames>Thorborn G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>56cc4eb9c53458.38754782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F6E5B64-D153-4E53-893A-7BF5E0A624E2</gtr:id><gtr:title>Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75a150024b30ef526e738c659e188ea9"><gtr:id>75a150024b30ef526e738c659e188ea9</gtr:id><gtr:otherNames>Pike R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56cc4ebd251c66.77025507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7473E40-5FCC-4163-8ED4-C3CD9158356B</gtr:id><gtr:title>Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567db690855d772e533bdfe18ff48de3"><gtr:id>567db690855d772e533bdfe18ff48de3</gtr:id><gtr:otherNames>Li SX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4eb998f9d4.00425103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051393E9-EE95-40F6-8CAB-EBB467693104</gtr:id><gtr:title>Resurrection of endogenous retroviruses in antibody-deficient mice.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56cc4ebb5a12e8.47230577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61504277-AE7D-496D-99D5-A38B055BF542</gtr:id><gtr:title>Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>56cc4ebbd51cb7.19319789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DB1F8A6-5E21-4C5E-BB8C-48C7A84F6855</gtr:id><gtr:title>B cells and TCR avidity determine distinct functions of CD4+ T cells in retroviral infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4576d9d57a17d2e8477c0265a4f68e3"><gtr:id>a4576d9d57a17d2e8477c0265a4f68e3</gtr:id><gtr:otherNames>Ploquin MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4ebc7ddd49.85757254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC2C3C1C-ED9C-423A-9F20-A5D6D846D688</gtr:id><gtr:title>Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cc4ebc12af79.49160296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD4F2014-D417-4B73-9DD3-55C5C535C225</gtr:id><gtr:title>Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21235522676f3848d94d0de56d316aeb"><gtr:id>21235522676f3848d94d0de56d316aeb</gtr:id><gtr:otherNames>Merkenschlager J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>56cc4eb79a8ed1.08961919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>615D9528-DADC-4AE8-93AA-0464CAB2BF9E</gtr:id><gtr:title>Negative impact of IFN-? on early host immune responses to retroviral infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dee4d2fb9ae34a64259c535c5ca94bae"><gtr:id>dee4d2fb9ae34a64259c535c5ca94bae</gtr:id><gtr:otherNames>Duley AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4ebb9d5e57.79641734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EEF3C5E-9A04-4552-9B3D-078AE604547A</gtr:id><gtr:title>Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d9d8852e01c123613ea93ead3bf6802"><gtr:id>5d9d8852e01c123613ea93ead3bf6802</gtr:id><gtr:otherNames>Antunes I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>56cc4ebe17e971.41844040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F390E496-687D-443F-9B5B-63369B9ED22B</gtr:id><gtr:title>Opposing Development of Cytotoxic and Follicular Helper CD4&amp;nbsp;T Cells Controlled by the TCF-1-Bcl6 Nexus.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46b31f814e0bf59ad1612db6379c0550"><gtr:id>46b31f814e0bf59ad1612db6379c0550</gtr:id><gtr:otherNames>Donnarumma T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c6a150de7a82.19405171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5AB5F25-2D66-4B70-A5DC-288C24BB25E0</gtr:id><gtr:title>B lymphocyte activation by coinfection prevents immune control of friend virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266709da30c6d35403936371e559db48"><gtr:id>266709da30c6d35403936371e559db48</gtr:id><gtr:otherNames>Marques R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a328bd2852f79.87498527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E53E6B-FAD7-42DF-865D-73A23E51C871</gtr:id><gtr:title>Establishing the follicular helper identity.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a54e4ccd802f58d67f9eef3a0a2961"><gtr:id>e5a54e4ccd802f58d67f9eef3a0a2961</gtr:id><gtr:otherNames>Kassiotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>56cc4ebd7b2d68.38639913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE9D691B-1848-47C9-921C-49F09112BF02</gtr:id><gtr:title>Immunology. Immunity benefits from a little suppression.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a54e4ccd802f58d67f9eef3a0a2961"><gtr:id>e5a54e4ccd802f58d67f9eef3a0a2961</gtr:id><gtr:otherNames>Kassiotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56cc4ebe521bb6.63430459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>875441F5-ABDC-4B00-A33B-59CE74614764</gtr:id><gtr:title>Noncognate interaction with MHC class II molecules is essential for maintenance of T cell metabolism to establish optimal memory CD4 T cell function.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e50222550ee35548e6fb217fb6564d49"><gtr:id>e50222550ee35548e6fb217fb6564d49</gtr:id><gtr:otherNames>De Riva A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56cc4ebe7b6593.69710298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E691E092-9E88-48AA-856B-B18E76281D83</gtr:id><gtr:title>Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49e472fa340329ea5fe7ab0f0d3df364"><gtr:id>49e472fa340329ea5fe7ab0f0d3df364</gtr:id><gtr:otherNames>Young GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>56cc4ebaadbbb8.28667256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6679A880-6039-4A93-8DBD-D8CBAFA7A405</gtr:id><gtr:title>Counterpoise between the microbiome, host immune activation and pathology.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ece6d2f371c1e009454b26e2451c56f3"><gtr:id>ece6d2f371c1e009454b26e2451c56f3</gtr:id><gtr:otherNames>Mavrommatis B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>56cc4ebb005981.54612971</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117581330</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>